Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Susan Ringdal Insider Profile
4 Followers
Susan Ringdal, Vice-President at Hikma Pharmaceuticals, holds 63.95K shares in Hikma Pharmaceuticals (Ticker: GB:HIK).
Susan Ringdal Hikma Pharmaceuticals (HIK)Vice-President
Hikma Pharmaceuticals (HIK)
Vice-President
Ranked #26,526 out of 98,743 Corporate Insiders
Profitable Transactions
4 out of 7 Profitable Transactions
Average Return
+5.80%
Average return per transaction
Time Frame
Compare to
Insider Roles
Vice-President
Roles that Susan Ringdal holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:May 17, 2021 - May 17, 2022
Return:+26.20%
The most profitable trade made by Susan Ringdal
Susan Ringdal's Trading History
List of latest transactions for each holding click on a transaction to see Susan Ringdal's performance on stock
You May Also Like
Susan Ringdal insider profile FAQ
What is the percentage of profitable transactions made by Susan Ringdal?
The percentage of profitable transactions made by Susan Ringdal is 57%.
What is the average return per transaction made by Susan Ringdal?
The average return per transaction made by Susan Ringdal is 5.80%.
What stocks does Susan Ringdal hold?
Susan Ringdal holds: GB:HIK stocks.
What was Susan Ringdal’s latest transaction?
Susan Ringdal latest transaction was an Uninformative Buy of 17.60K.
What was Susan Ringdal's most profitable transaction?
Susan Ringdal’s most profitable transaction was an Informative Sell of GB:HIK stock on May 17, 2021. The return on the trade was 26.20%.
What is Susan Ringdal's role in Hikma Pharmaceuticals?
Susan Ringdal's role in Hikma Pharmaceuticals is Vice-President.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.